Back to Search
MARK PILKINTON, M.D.
M.D.
Infectious Disease Physician
NPI: 1184868481IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 2009
Research & Publications (6)
Deletion of the p107/p130-binding domain of Mip130/LIN-9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex.
PMID 19619530·Exp Cell Res·2009
7-preclinical
Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.
PMID 17563750·Oncogene·2007
7-preclinical
Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1.
PMID 17098733·J Biol Chem·2007
7-preclinical
A mutant allele of BARA/LIN-9 rescues the cdk4-/- phenotype by releasing the repression on E2F-regulated genes.
PMID 16730350·Exp Cell Res·2006
7-preclinical
Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.
PMID 15169789·J Biol Chem·2004
7-preclinical
Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function.
PMID 15155623·Infect Immun·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1161 21ST AVE S, MCN A2200
NASHVILLE, TN 37232 - Phone
- (615) 322-2035
Quick Facts
- NPI
- 1184868481
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 17
- Publications
- 6
Are you this provider?
Claim Your Profile